Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Reasonable Alternative to Biopsy of Palpable Breast Lesions with Benign Imaging Characteristics Evaluated

By MedImaging International staff writers
Posted on 22 Dec 2009
Short-term follow-up is a practical alternative to invasive biopsy of palpable breast lesions with benign imaging features, especially in younger women with probable fibroadenoma (non-cancerous tumors that frequently occur in women during their reproductive years), according to recent research.

The study, published in the December 2009 issue of the American Journal of Roentgenology (AJR), was performed at the University of Virginia (Charlottesville, VA, USA), and consisted of a group of 320 women with 375 palpable masses with benign features for which short-term follow-up was recommended. "We found that only one case of cancer was diagnosed for which short-term follow-up had been recommended,” said Jennifer A. Harvey, M.D., lead author of the study.

"Our study of palpable breast lesions with benign features showed an acceptably low prevalence of breast cancer--low that short-term follow-up is a reasonable alternative to biopsy,” continued Dr. Harvey. "Application of the results of our study may reduce the number of biopsies that result in benign findings. There is also significant cost savings associated with using short-term follow-up rather than immediate biopsy.” 

Related Links:

University of Virginia


Digital Radiography System (Ceiling Free)
Digix CF Series
Medical Radiographic X-Ray Machine
TR30N HF
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
High-Precision QA Tool
DEXA Phantom

Channels

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.